- Email: [email protected]
3rd Special Issue: Pharmacoeconomics & Outcomes Research in Asia
3rd Special Issue: Pharmacoeconomics & Outcomes Research in Asia Special Issue Co-Editors Vithaya Kulsomboon, PhD Associate Professor & Associate Dean for Planning and Development Faculty of Pharmaceutical Sciences Chulalongkorn University Bangkok, Thailand E-mail: [email protected]
Bong-min Yang, PhD Professor of Economics School of Public Health Seoul National University Seoul, South Korea E-mail: [email protected]
Shanlian Hu, MD, MSc Professor of Health Economics School of Public Health Fudan University Shanghai, China E-mail: [email protected]
The International Society for Pharmacoeconomics and Outcomes Research recognizes the following companies for their financial support of this Value in Health Special Issue: Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation Novo Nordisk A/S Novo Nordisk China The opinions or views expressed in this Value in Health Special Issue are those of the authors and do not necessarily reflect the opinions or recommendations of the publisher, Special Issue Co-Editors, sponsor(s) or ISPOR. Articles may discuss pharmaceutical products and/or uses of products that have not been approved by the US Food and Drug Administration or other regulatory authorities outside the United States.
Bong-min Yang, PhD Professor of Economics School of Public Health Seoul National University Seoul, South Korea E-mail: [email protected]
Shanlian Hu, MD, MSc Professor of Health Economics School of Public Health Fudan University Shanghai, China E-mail: [email protected]
The International Society for Pharmacoeconomics and Outcomes Research recognizes the following companies for their financial support of this Value in Health Special Issue: Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation Novo Nordisk A/S Novo Nordisk China The opinions or views expressed in this Value in Health Special Issue are those of the authors and do not necessarily reflect the opinions or recommendations of the publisher, Special Issue Co-Editors, sponsor(s) or ISPOR. Articles may discuss pharmaceutical products and/or uses of products that have not been approved by the US Food and Drug Administration or other regulatory authorities outside the United States.